Teleflex (NYSE:TFX) Reaches New 1-Year High – What’s Next?

Shares of Teleflex Incorporated (NYSE:TFX) hit a new 52-week high during trading on Monday . The stock traded as high as $140.80 and last traded at $142.1860, with a volume of 57227 shares traded. The stock had previously closed at $136.71.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $140.00 to $160.00 in a research report on Monday, June 8th. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a report on Monday, April 13th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price target for the company from $135.00 to $155.00 in a research note on Friday, May 8th. Raymond James Financial reiterated an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Finally, Wall Street Zen cut shares of Teleflex from a “hold” rating to a “sell” rating in a research report on Saturday. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Teleflex currently has an average rating of “Hold” and a consensus target price of $148.90.

Teleflex Stock Up 0.3%

The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The stock’s 50 day simple moving average is $131.27 and its 200 day simple moving average is $121.97. The firm has a market cap of $6.20 billion, a P/E ratio of -6.14, a price-to-earnings-growth ratio of 1.04 and a beta of 0.81.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business’s revenue was up 32.3% on a year-over-year basis. During the same period last year, the company earned $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Research analysts anticipate that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, May 22nd. Teleflex’s payout ratio is currently -5.96%.

Institutional Trading of Teleflex

Institutional investors and hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC boosted its position in shares of Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after buying an additional 1,956,811 shares during the last quarter. Irenic Capital Management LP purchased a new stake in Teleflex in the 1st quarter valued at $104,061,000. Norges Bank purchased a new stake in Teleflex in the 4th quarter valued at $66,076,000. Wolf Hill Capital Management LP bought a new position in Teleflex during the 4th quarter valued at $47,405,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Teleflex by 123.9% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company’s stock valued at $80,855,000 after acquiring an additional 365,663 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.